Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) Meeting Abstract
| Authors: | Bartlett, N. L.; Sehn, L. H.; Assouline, S. E.; Bosch, F.; Diefenbach, C. S. M.; Flinn, I.; Hong, J.; Kim, W. S.; Matasar, M. J.; Nastoupil, L. J.; Schuster, S. J.; Shadman, M.; Yoon, S. S.; Bender, B.; Kwan, A.; Cunlin, W.; Wei, M. C.; Yin, S.; Yousefi, K.; Budde, L. E. |
| Abstract Title: | Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 428s |
| Language: | English |
| ACCESSION: | WOS:000487345806280 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7518 |
| Notes: | Meeting Abstract: 7518 -- Source: Wos |
